1. Envista rebranded its imaging business, KaVo, as Dexis.
2. Envista received FDA 510(k) clearance for an “assisted intelligence” nerve-tracing feature in its DTX Studio Clinic software.
3. Envista received letters from 118 environmental, consumer and children’s groups asking the company to stop producing amalgam.
4. Envista and DSO Vitaldent have renewed their partnership.
5. Pacific Dental Services began using Envista’s AI-powered imaging software at its locations, then extended and expanded the partnership to include Spark clear aligners.
6. Envista completed the divestiture of its KaVo (now Dexis) dental treatment unit and instrument business.
At the Becker's 5th Annual Future of Dentistry Roundtable, taking place September 14-15 in Chicago, dental leaders and executives will gain insights into emerging technologies, practice growth strategies and the evolving landscape of dental care delivery, with a focus on innovation, patient experience and operational excellence. Apply for complimentary registration now.
